Home Insights Due Diligence Essential in Selecting CMO Due Diligence Essential in Selecting CMO June 1, 2010 June 1, 2010 (Vol. 30, No. 11) Firms Must Look Beyond Credentials to Find the Right Partner for Their Manufacturing Needs BiomanufacturingGenetic Engineering and BiotechnologyNanoparticlesNanotechnologyTechnology and Computational Biology Also of Interest Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Ricoh and ERS Genomics Sign CRISPR Licensing Agreement Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma IIT Madras Partners with Vellon Space to Advance Biomanufacturing in Microgravity International Women’s Day, Nanoparticles and Delivery, Novo Nordisk’s Expansion, and Organoids for Congenital Conditions Metal-Organic Nanoparticles Enable Better Vaccine Delivery, Stronger Immune Response Related Media Boston and Bioprocessing: GEN Reports Live from the First Day at BPI Perfect Pitch: Genome Editing Pioneer Fyodor Urnov on Commercializing CRISPR Therapies and Epigenomic Tuning Excitement in Oakland: A Report from SynBioBeta Celebrating DNA: Matthew Cobb's Reflections on the Double Helix Breathing Oxygen Back into the Biological Conversation Global Single-Use Network Support Assurance of Supply Related Content Machine Learning Can Spot Tumor-Reactive TCRs, Speed Immunotherapies Ricoh and ERS Genomics Sign CRISPR Licensing Agreement Lab Space Giant Alexandria Real Estate Navigates AI’s Impact on Biopharma IIT Madras Partners with Vellon Space to Advance Biomanufacturing in Microgravity